Skip to content
VuFind
Book Bag:
0
items
(Full)
Institutional Login
Language
English
Deutsch
All Fields
Title
Author
Subject
ISBN/ISSN
K10+-PPN
OCLC Number
Find
Advanced
Start
Epirubicin and cyclophosphamid...
Cite this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Export to RDF
Export to BibTeX
Export to RIS
Save to List
Permanent link
Epirubicin and cyclophosphamide-induced hematologic changes and recommendation for monitoring in clinical practice
Saved in:
Bibliographic Details
Main Author:
Pleimes, Dirk
(Author)
Format:
Book/Monograph
Thesis
Language:
English
Published:
Heidelberg
2020
Subjects:
Hochschulschrift
Online Access:
Author Notes:
vorgelegt von Dirk Pleimes ; Doktorvater: Herr Prof. Dr. med. Gerd Mikus
Description
Staff View
Description
Description not available.
Similar Items
Short term quality of life with epirubicin-fluorouracil-cyclophosphamid (FEC) and sequential epirubicin/cyclophosphamid-docetaxel (EC-DOC) chemotherapy in patients with primary breast cancer: results from the prospective multi-center randomized ADEBAR trial
by: Schwentner, Lukas Paul, et al.
Published: (2016)
Practical recommendations for therapy and monitoring of mogamulizumab patients in Germany
by: Assaf, Chalid, et al.
Published: (2025)
Intense dose-dense sequential chemotherapy with epirubicin, paclitaxel, and cyclophosphamide compared with conventionally scheduled chemotherapy in high-risk primary breast cancer: mature results of an AGO Phase III Study
Published: (2010)
Practice recommendations: A new type of article in Pediatric Transplantation
by: Filler, Guido, et al.
Published: (2016)
The application of standards and recommendations to clinical ethics consultation in practice: an evaluation at German hospitals
by: Schochow, Maximilian, et al.
Published: (2017)